Prediction Case File
YouTubeEvaluation Complete

Netflix Stock Is FINALLY A Buy!

1 extracted signal · 0 resolved · 0 still active

The Patient Investor profile imageThe Patient InvestorIndependent analyst profile
Source published
16 Jul 2026, 21:29 UTC
Recorded by Tahlil Plus
16 Jul 2026, 22:43 UTC
Video preview for Netflix Stock Is FINALLY A Buy!
Source overview

AI-generated source summary

Netflix reported a slight miss on revenue and EPS for the past quarter, with revenue at $12.56 billion versus an estimate of $12.59 billion, and EPS at $0.80 versus an estimated $0.79. Despite these results, the company expects its advertising revenue to double year-over-year to $3 billion. The company is also changing its reporting frequency for viewership data from semi-annually to annually. Based on a valuation model using analyst estimates for future EPS growth of 15% annually and a trailing P/E ratio of 23, Netflix's stock is currently trading at a forward P/E of approximately 20 times earnings. This valuation is considered cheap for a company with Netflix's growth and return on invested capital profile. The stock is currently trading around $74.35, and the analysis suggests a potential target of $142.83, representing an upside of over 110% over the next five years. The fail bound, below which the bullish thesis would be invalidated, is estimated at $50.00.

AI-generated summary based on the source content.

Live evaluation

Signal outcomes at a glance

Evaluation Complete
Signals
1
Extracted from this source
Open
0
Still being tracked
Successful
0
Resolved successfully
Failed
0
Resolved unsuccessfully
Other
1
Cancelled, invalid or excluded
Resolved success
—
0 resolved; open signals omitted
Extracted intelligence

Signals in this source

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  3. Market predictions extracted

    1 eligible signal linked to this case.

  4. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  5. Source processing completed

    Source analysis and structured extraction completed.

  6. First prediction resolved

    The first evaluable outcome in this case reached a terminal result.

  7. Case evaluation completed

    All evaluable predictions in this case reached terminal outcomes.

Analyst snapshot

The Patient Investor

Platform-wide history, separate from this source evaluation.

Reliability
47.9
Tracked signals
355
Historical success
34.9%
View full analyst profile →
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

Continue the evidence trail